Tag Archive for: infection management

Biocomposites invests in InfectoTest GmbH – developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI)

/in

InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose PJI in less than five minutes It is based on InfectoTest’s ability to detect the infection in tiny quantities of synovial fluid using a unique method of electrochemical analysis The investment signifies Biocomposites’ ongoing commitment to providing products for the management of […]

Read more

Biocomposites announces two new Phase II clinical trials of STIMULAN VG – a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin – in the U.S.

/in

BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]

Read more

Biocomposites expands its international presence by opening new sales and distribution office in Italy

/in

Biocomposites SRL will support sales of STIMULAN, NanoBone, genex and SYNICEM Spacers throughout Italy New team has been hired and first sales have already taken place Keele, UK, 16 January 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue, is pleased […]

Read more

Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2

/in

RENOVITE® BMP-2 is being developed as an alternative to bone graft materials for interbody spinal fusion It is the first product based on RENOVITE®, Renovos’ novel nanoclay therapeutic delivery platform for precision regenerative medicine Keele, UK, 4 January 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating […]

Read more

Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK

/in

SYNICEM™ hip, knee and shoulder spacers are preformed and loaded with gentamicin to maintain space and aid treatment of infection Already successfully used in UK patients as part of their infection treatment strategies Keele, UK, 21 November 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in […]

Read more